- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05793970
IL6 on Umbilical Cord (Evaluation of IL-6 Levels on Umbilical Cord) (INFIL-6)
Evaluation of IL-6 Levels on Umbilical Cord
Study Overview
Status
Conditions
Detailed Description
The labor will be managed according to the local protocol and 5mL of blood will collected from the umbilical artery soon after birth to determine the IL-6 values. CardioTocography (CTG) traces will be retrospectively reviewed by two expert operators that will be blinded to the IL-6 results and will categorize them as "inflammatory" or "not inflammatory".
Inflammatory pattern will be defined in presence of 1) inappropriately high FHR for the given gestational age and/or 2) an increase >10% compared with the FHR baseline values at admission without preceding deceleration with/without reduced variability or absent cycling.
The association between CTG findings as the umbilical levels of IL6 will be analyzed.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Tullio Ghi, Professor
- Phone Number: +390521702434
- Email: tullio.ghi@unipr.it
Study Locations
-
-
-
Parma, Italy, 43123
- Recruiting
- University Hospital of Parma
-
Contact:
- Tullio Ghi, Professor
-
Contact:
- Elvira di Pasquo, MD
-
Roma, Italy, 00186
- Recruiting
- Fondazione Universitaria Policlinico Gemelli
-
Contact:
- Antonio Lanzone, Professor
-
Contact:
- Alessandra Familiari, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- singleton pregnancies at term submitted to a continuous CTG tracing during labor
Exclusion Criteria:elective Cesarean Delivery, maternal tachycardia or pyrexia >38°C, drugs assumption
-
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IL6 Levels
Time Frame: IL6 will be measured on the umbilical blood sampled within 5 minutes after birth
|
correlation between intrapartum CTG findings and IL-6 levels on the arterial cord
|
IL6 will be measured on the umbilical blood sampled within 5 minutes after birth
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tullio Ghi, Professor, University of Parma
Publications and helpful links
General Publications
- Jung E, Romero R, Yeo L, Diaz-Primera R, Marin-Concha J, Para R, Lopez AM, Pacora P, Gomez-Lopez N, Yoon BH, Kim CJ, Berry SM, Hsu CD. The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications. Semin Fetal Neonatal Med. 2020 Aug;25(4):101146. doi: 10.1016/j.siny.2020.101146. Epub 2020 Oct 23.
- Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007 Sep;50(3):652-83. doi: 10.1097/GRF.0b013e31811ebef6.
- Romero R, Chaemsaithong P, Docheva N, Korzeniewski SJ, Tarca AL, Bhatti G, Xu Z, Kusanovic JP, Chaiyasit N, Dong Z, Yoon BH, Hassan SS, Chaiworapongsa T, Yeo L, Kim YM. Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response. J Perinat Med. 2016 Jan;44(1):53-76. doi: 10.1515/jpm-2015-0121.
- Ren J, Qiang Z, Li YY, Zhang JN. Biomarkers for a histological chorioamnionitis diagnosis in pregnant women with or without group B streptococcus infection: a case-control study. BMC Pregnancy Childbirth. 2021 Mar 25;21(1):250. doi: 10.1186/s12884-021-03731-7.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 561/2021/OSS/AOUPR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intrauterine Infection
-
Sohag UniversityActive, not recruitingIUD; Complications, Infection or Inflammation | IUD (Intrauterine Device) MalpositionEgypt
-
Washington University School of MedicineCompletedIntrauterine ResuscitationUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedIntrauterine DeviceTurkey
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
Assiut UniversityCompletedIntrauterine DeviceEgypt
-
Cairo UniversityCompleted
-
Centre Hospitalier Universitaire de Saint EtienneSAINBIOSECompleted
-
Helsinki University Central HospitalCompletedIntrauterine ContraceptionFinland
-
Assiut UniversityCompleted
-
Cairo UniversityCompletedIntrauterine DeviceEgypt